• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    mAbxience, Egis Ink Deal For Biosimilars In Central Europe

    PRESS RELEASE

    Teva, mAbxience Add New Oncology Biosimilar To Partnership

    GLOBENEWSWIRE

    MAbxience Names New Chief Executive Officer

    CONTRACT PHARMA

    mAbxience Appoints Jurgen Van Broeck as New CEO

    PR NEWSWIRE

    Teva enters into oncology biosimilar licensing agreement

    EUROPEAN PHARMACEUTICAL REVIEW

    Teva & mAbxience Announce Licensing Agreement for Oncology Biosimilar Candidate

    BUSINESSWIRE

    Teva inks cancer biosimilar marketing pact with mAbxience

    FIERCE PHARMA

    MAbxience And Biosidus Sign CDMO Agreement For Fabry Disease Drug

    PRESS RELEASE

    mAbxience Continues MCE with ABEC Single-Use Bioreactor Technology

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.